Probiotic Lactobacilli Isolated from Kefir Promote Down-Regulation of Inflammatory Lamina Propria T Cells from Patients with Active IBD

• Main Authors: Renata Curciarello (Author), Karina E. Canziani (Author), Ileana Salto (Author), Emanuel Barbiera Romero (Author), Andrés Rocca (Author), Ivan Doldan (Author), Emmanuel Peton (Author), Santiago Brayer (Author), Alicia M. Sambuelli (Author), Silvina Goncalves (Author), Pablo Tirado (Author), Gustavo J. Correa (Author), Martín Yantorno (Author), Laura Garbi (Author), Guillermo H. Docena (Author), María de los Ángeles Serradell (Author), Cecilia I. Muglia (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ulcerative colitis and Crohn's disease, the two main forms of inflammatory bowel disease (IBD), are immunologically mediated disorders. Several therapies are focused on activated T cells as key targets. Although Lactobacillus kefiri has shown anti-inflammatory effects in animal models, few stud...